Clover Health Investments CLOV Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value at other companies

Alignment HealthcareALHC

——

Privia Health Group, Inc.PRVA

——

CNO Financial GroupCNO

——

Other financials

Income statement

See full

Revenue$749.2M+62.0%

Operating income$27.3M+2,246%

Net income$27.3M+2,246%

EPS (diluted)$0.05—

Balance sheet

See full

Cash & equivalents$173.3M+11.5%

Total debt$3.3M-0.9%

Total equity$339.4M+1.0%

Total assets$697.7M+19.5%

Cash flow

See full

Operating cash flow$107.9M+762%

CapEx$854.0K+362%

Free cash flow$107.0M+750%

Valuation

See full

Market cap$2.67B-49.7%

P/S1.2×-2.4×

Profitability

See full

Operating margin-2.6%+3.5pp

Net margin-2.6%+2.8pp

FCF margin-10.3%—

Returns & leverage

See full

Return on equity-16.9%-170pp

Debt / equity0×0.0×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by Clover Health Investments in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.

The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clover Health Investments's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Clover Health Investments's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value?: Clover Health Investments (CLOV) reported share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value of $900K in Q1 2026.
How has Clover Health Investments's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value changed year-over-year?: Clover Health Investments's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value decreased by 97.0% year-over-year, from $29.9M to $900K.